Facts and artefacts of coagulation assays for factor Xa inhibitors.
Haas
Sylvia
S
D000284:Administration, Oral; D016477:Artifacts; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests / Q000592:standards; D002138:Calibration; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring / Q000379:methods* / Q000592:standards; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D006801:Humans; D009025:Morpholines / Q000494:pharmacology; D010314:Partial Thromboplastin Time; D011237:Predictive Value of Tests; D011517:Prothrombin Time; D015203:Reproducibility of Results; D000069552:Rivaroxaban; D013876:Thiophenes / Q000494:pharmacology; D013916:Thrombelastography; D013917:Thrombin / Q000378:metabolism; D013997:Time Factors
D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban; D013917:Thrombin